Phase 2-3 Trial: Prevention of the Progression to Moderate and Severe COVID-19 in SARS-CoV-2-Infected Non-Hospitalized Adults With Inhaled siRNA-Based MIR 19

M Khaitov, A Nikonova, V Smirnov, I Shilovsky, I Kofiadi, E Ruzanova, V Teplykh, D Makarov, A Vertichikh, S Teplykh, D Alpenidze, E Muldagalieva, E Simakina, T Ivanushkina, K Zakharov, L Melnikova, D Medvedev, O Zuev, D Kudlay, D KruchkoI Berzin, R Valenta, V Skvortsova

Research output: Journal article (peer-reviewed)Journal article

Fingerprint

Dive into the research topics of 'Phase 2-3 Trial: Prevention of the Progression to Moderate and Severe COVID-19 in SARS-CoV-2-Infected Non-Hospitalized Adults With Inhaled siRNA-Based MIR 19'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions